Working… Menu

Gene Therapy for Achromatopsia (CNGB3) (CNGB3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03001310
Recruitment Status : Completed
First Posted : December 23, 2016
Last Update Posted : January 22, 2021
EMAS Pharma
Syne Qua Non Limited
Information provided by (Responsible Party):
MeiraGTx UK II Ltd

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 25, 2019
Actual Study Completion Date : October 25, 2019
Certification/Extension First Submitted : October 14, 2020